OBJECTIVES: The purpose of this study was to determine whether abnormalities of calcium cycling explain ventricular action potential (AP) oscillations and cause electrocardiogram T-wave alternans (TWA). BACKGROUND: Mechanisms explaining why heart failure patients are at risk for malignant ventricular arrhythmias (ventricular tachycardia [VT]/ventricular fibrillation [VF]) are unclear. We studied whether oscillations in human ventricular AP explain TWA and predict VT/VF, and used computer modeling to suggest potential cellular mechanisms. METHODS: We studied 53 patients with left ventricular ejection fraction 28 +/- 8% and 18 control subjects. Monophasic APs were recorded in the right ventricle (n = 62) and/or left ventricle (n = 9) at 109 beats/min. RESULTS: Alternans of AP amplitude, computed spectrally, had higher magnitude in study patients than in controls (p = 0.03), particularly in AP phase II (p = 0.02) rather than phase III (p = 0.10). The AP duration and activation restitution (n = 11 patients) were flat at 109 beats/min and did not explain TWA. In computer simulations, only reduced sarcoplasmic reticulum calcium uptake explained our results, causing calcium oscillations, AP amplitude alternans, and TWA that were all abolished by calcium clamping. On prospective follow-up for 949 +/- 553 days, 17 patients had VT/VF. The AP amplitude alternans predicted VT/VF (p = 0.04), and was 78% concordant with simultaneous TWA (p = 0.003). CONCLUSIONS: Patients with systolic dysfunction show ventricular AP amplitude alternans that prospectively predicted VT/VF. Alternans in AP amplitude, but not variations in AP duration or conduction, explained TWA at < or =109 beats/min. In computer models, these findings were best explained by reduced sarcoplasmic reticulum calcium uptake. Thus, in heart failure patients, in vivo AP alternans may reflect cellular calcium abnormalities and provide a mechanistic link with VT/VF.
OBJECTIVES: The purpose of this study was to determine whether abnormalities of calcium cycling explain ventricular action potential (AP) oscillations and cause electrocardiogram T-wave alternans (TWA). BACKGROUND: Mechanisms explaining why heart failurepatients are at risk for malignant ventricular arrhythmias (ventricular tachycardia [VT]/ventricular fibrillation [VF]) are unclear. We studied whether oscillations in human ventricular AP explain TWA and predict VT/VF, and used computer modeling to suggest potential cellular mechanisms. METHODS: We studied 53 patients with left ventricular ejection fraction 28 +/- 8% and 18 control subjects. Monophasic APs were recorded in the right ventricle (n = 62) and/or left ventricle (n = 9) at 109 beats/min. RESULTS: Alternans of AP amplitude, computed spectrally, had higher magnitude in study patients than in controls (p = 0.03), particularly in AP phase II (p = 0.02) rather than phase III (p = 0.10). The AP duration and activation restitution (n = 11 patients) were flat at 109 beats/min and did not explain TWA. In computer simulations, only reduced sarcoplasmic reticulum calcium uptake explained our results, causing calcium oscillations, AP amplitude alternans, and TWA that were all abolished by calcium clamping. On prospective follow-up for 949 +/- 553 days, 17 patients had VT/VF. The AP amplitude alternans predicted VT/VF (p = 0.04), and was 78% concordant with simultaneous TWA (p = 0.003). CONCLUSIONS:Patients with systolic dysfunction show ventricular AP amplitude alternans that prospectively predicted VT/VF. Alternans in AP amplitude, but not variations in AP duration or conduction, explained TWA at < or =109 beats/min. In computer models, these findings were best explained by reduced sarcoplasmic reticulum calcium uptake. Thus, in heart failurepatients, in vivo AP alternans may reflect cellular calcium abnormalities and provide a mechanistic link with VT/VF.
Authors: Marcus L Koller; Sebastian K G Maier; Anna R Gelzer; Wolfgang R Bauer; M Meesmann; Robert F Gilmour Journal: Circulation Date: 2005-09-13 Impact factor: 29.690
Authors: Rodrigo Weber Dos Santos; Fernando Otaviano Campos; Leandro Neumann Ciuffo; Anders Nygren; Wayne Giles; Hans Koch Journal: J Cardiovasc Electrophysiol Date: 2006-05
Authors: Sanjiv M Narayan; Joseph M Smith; Bruce D Lindsay; Michael E Cain; Victor G Dávila-Román Journal: Am J Cardiol Date: 2006-01-17 Impact factor: 2.778
Authors: Gautam G Lalani; Amir Schricker; Michael Gibson; Armand Rostamian; David E Krummen; Sanjiv M Narayan Journal: J Am Coll Cardiol Date: 2012-02-07 Impact factor: 24.094
Authors: David E Krummen; Justin Hayase; Stephen P Vampola; Gordon Ho; Amir A Schricker; Gautam G Lalani; Tina Baykaner; Taylor M Coe; Paul Clopton; Wouter-Jan Rappel; Jeffrey H Omens; Sanjiv M Narayan Journal: J Cardiovasc Electrophysiol Date: 2015-09-06
Authors: Sanjiv M Narayan; Michael R Franz; Paul Clopton; Etienne J Pruvot; David E Krummen Journal: Circulation Date: 2011-06-06 Impact factor: 29.690
Authors: Richard L Verrier; Thomas Klingenheben; Marek Malik; Nabil El-Sherif; Derek V Exner; Stefan H Hohnloser; Takanori Ikeda; Juan Pablo Martínez; Sanjiv M Narayan; Tuomo Nieminen; David S Rosenbaum Journal: J Am Coll Cardiol Date: 2011-09-20 Impact factor: 24.094
Authors: Byron N Roberts; Pei-Chi Yang; Steven B Behrens; Jonathan D Moreno; Colleen E Clancy Journal: Am J Physiol Heart Circ Physiol Date: 2012-08-10 Impact factor: 4.733